Land: Armenië
Taal: Engels
Bron: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
enalapril (enalapril maleate)
Merck Sharp & Dohme B.V.
enalapril (enalapril maleate)
20mg
tablets
Prescription
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Renitec 5 mg Tablets Renitec 10 mg Tablets Renitec 20 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Renitec 5 mg Each tablet contains 5 mg of enalapril maleate. Excipient: each tablet contains 198 mg of lactose monohydrate. Renitec 10 mg Each tablet contains 10 mg of enalapril maleate. Excipient: each tablet contains 164 mg of lactose monohydrate. Renitec 20 mg Each tablet contains 20 mg of enalapril maleate. Excipient: each tablet contains 154 mg of lactose monohydrate. Excipient(s) with known effect: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets. Strength Appearance Country 5 mg White, rounded triangle shaped tablet, one side scored* the other side marked MSD 712 Austria, Finland, Germany, Ireland, The Netherlands, Sweden, United Kingdom White, barrel shaped tablet, one side scored* the other side marked RENITEC Belgium, Luxemburg, France, Portugal, Spain White, round shaped tablet, one side scored*, the other side marked 712 Italy White, round flat tablet, one side scored* other side plain Greece 10 mg Rust Red, rounded triangle shaped tablet, one side scored*, the other side marked MSD 713 Austria, Finland, Germany, Ireland, The Netherlands, Sweden, United Kingdom 20 mg Peach, rounded triangle shaped tablet, one side scored*, the other side marked MSD 714 Austria, Finland, Germany, Ireland, The Netherlands, Sweden, United Kingdom Peach, barrel shaped tablet, one side scored*, the other side marked RENITEC Belgium, France, Luxembourg, Portugal Peach, round shaped tablet, one side scored quartersect*, the other side marked 714 Italy Peach, barrel shaped tablet, one side scored* MSDE, the other side marked RENITEC Spain Peach, round flat tablet, one side scored* other side plain Greece *The scoreline is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • Treatment of Hypertension • Treatment of Symptomatic Hear Lees het volledige document